ロード中...
COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY
PURPOSE: To compare the efficacy of intravitreal injection of ranibizumab (IVR) monotherapy and laser therapy for treatment-requiring retinopathy of prematurity (ROP) in Zone II. METHODS: A prospective, randomized, controlled single-center trial was applied from January 2014 to December 2014; infant...
保存先:
| 出版年: | Retina |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Retina
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5388026/ https://ncbi.nlm.nih.gov/pubmed/27529839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000001241 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|